Evolus (EOLS) Exchange Rate Effect (2022 - 2026)
Evolus' (EOLS) quarterly Exchange Rate Effect came in at -$10000.0 in Q1 2026, down 115.15% YoY from $66000.0 in Q1 2025, and up 97.7% on a QoQ basis from -$435000.0 in Q4 2025.
Evolus (EOLS) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Evolus (EOLS) has 5 years of Exchange Rate Effect data on file, last reported at -$10000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 115.15% year-over-year to -$10000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $178000.0 (up 163.12% YoY) and the FY2025 annual result came in at $254000.0, up 153.14% from the prior year.
- Exchange Rate Effect grew to -$10000.0 in Q1 2026, from -$435000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $384000.0 in Q3 2025 to a low of -$435000.0 in Q4 2025.
- A 5-year average of -$38882.4 and a median of -$62000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 220.67% — and 2025, when it surged 643.18%.
- Tracing EOLS's Exchange Rate Effect over 5 years: stood at $31000.0 in 2022, then jumped by 477.42% to $179000.0 in 2023, then slumped by 220.67% to -$216000.0 in 2024, then sank by 101.39% to -$435000.0 in 2025, then surged by 97.7% to -$10000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$10000.0 (Q1 2026), -$435000.0 (Q4 2025), and $384000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evolus | 550.84 Mn | 505.67 Mn | 57.18 Mn | -170,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -170,000.00 |
| Jun 30, 2026 | -170,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -435,000.00 |
| Dec 31, 2025 | -435,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Sep 30, 2024 | -88,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -44,000.00 |
| Mar 31, 2024 | -130,000.00 |
| Mar 31, 2024 | -130,000.00 |